WDFY4 and lung adenocarcinoma: The data presented herein indicate that the upregulation of WDFY4 exerts a substantial inhibitory effect on the proliferation of lung adenocarcinoma cells both in vitro and in vivo, thereby highlighting its potential as a viable therapeutic target for the treatment of lung adenocarcinoma.